巨细胞动脉炎动脉壁重塑相关microRNA及其靶基因网络鉴定
该研究对93例未治疗患者颞动脉活检组织进行miRNA表达分析,其中GCA阳性54例、GCA临床诊断但活检阴性17例、非GCA阴性22例。发现GCA阳性动脉中356个miRNA失调,促合成型miRNA过表达、促收缩型miRNA低表达,其靶基因参与动脉重塑和免疫调节,且与内膜增生程度相关。部分miRNA可区分活检阴性GCA与非GCA动脉,提示其作为GCA生物标志物的潜力。
要点
- GCA阳性颞动脉中356个miRNA失调,78个显著低表达、22个显著高表达(>2倍)。
- 促合成型miRNA(miR-21-3p/-21-5p/-146a-5p/-146b-5p/-424-5p)过表达,促收缩型miRNA低表达。
- miR-21-3p/-21-5p/-146a-5p/-146b-5p/-365a-3p可区分活检阴性GCA与非GCA颞动脉。
核心结论
- GCA动脉病变中存在调控血管平滑肌细胞表型和内膜增生的失调miRNA,为GCA发病机制提供新见解,并提示其作为诊断和预后生物标志物的潜力。
研究设计与样本
- 纳入93例未治疗患者的福尔马林固定石蜡包埋颞动脉活检组织:GCA临床诊断且活检阳性54例、GCA临床诊断但活检阴性17例、非GCA活检阴性22例。
- 采用miRCURY LNA miRNome Human PCR Panels和定量实时PCR进行miRNA表达分析,并使用miRDB和STRING数据库进行靶基因预测和通路富集分析。
主要发现
- 与未患GCA的对照相比,活检阳性的GCA动脉中356个miRNA失调,其中78个显著低表达、22个显著高表达超过2倍。
- 活检阳性的GCA动脉以促合成型miRNA(miR-21-3p/-21-5p/-146a-5p/-146b-5p/-424-5p)显著过表达和促收缩型miRNA(miR-23b-3p/-125a-5p/-143-3p/-143-5p/-145-3p/-145-5p/-195-5p/-365a-3p)低表达为特征。
- 这些miRNA靶向参与动脉重塑和免疫系统调节的基因通路,其表达与GCA患者活检组织中内膜增生程度相关。
- miR-21-3p/-21-5p/-146a-5p/-146b-5p/-365a-3p的表达可区分活检阴性的GCA动脉与非GCA颞动脉。
临床怎么用
- 检测促合成型和促收缩型miRNA表达谱可能辅助GCA诊断,尤其是在活检阴性但临床怀疑GCA时。
- miRNA表达与内膜增生程度相关,提示其可能用于评估GCA疾病活动和血管重塑严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify dysregulated microRNAs (miRNAs) and their gene targets in temporal arteries from GCA patients, and determine their association with GCA pathogenesis and related arterial wall remodelling. METHODS: We included 93 formalin-fixed, paraffin-embedded temporal artery biopsies (TABs) from treatment-naïve patients: 54 positive and 17 negative TABs from clinically proven GCA patients, and 22 negative TABs from non-GCA patients. miRNA expression analysis was performed with miRCURY LNA miRNome Human PCR Panels and quantitative real-time PCR. miRNA target gene prediction and pathway enrichment analysis was performed using the miRDB and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) databases, respectively. RESULTS: Dysregulation of 356 miRNAs was determined in TAB-positive GCA arteries, among which 78 were significantly under-expressed and 22 significantly overexpressed above 2-fold, when compared with non-GCA controls. Specifically, TAB-positive GCA arteries were characterized by a significant overexpression of 'pro-synthetic' (miR-21-3p/-21-5p/-146a-5p/-146b-5p/-424-5p) and under-expression of 'pro-contractile' (miR-23b-3p/-125a-5p/-143-3p/-143-5p/-145-3p/-145-5p/-195-5p/-365a-3p) vascular smooth muscle cell phenotype-associated regulatory miRNAs. These miRNAs targeted gene pathways involved in the arterial remodelling and regulation of the immune system, and their expression correlated with the extent of intimal hyperplasia in TABs from GCA patients. Notably, the expression of miR-21-3p/-21-5p/-146a-5p/-146b-5p/-365a-3p differentiated between TAB-negative GCA arteries and non-GCA temporal arteries, revealing these miRNAs as potential biomarkers of GCA. CONCLUSION: Identification of dysregulated miRNAs involved in the regulation of the vascular smooth muscle cell phenotype and intimal hyperplasia in GCA arterial lesions, and detection of their expression profiles, enables a novel insight into the complexity of GCA pathogenesis and implies their potential utilization as diagnostic and prognostic biomarkers of GCA.
引用
- Bolha L, Pižem J, Frank-Bertoncelj M, et al. Identification of microRNAs and their target gene networks implicated in arterial wall remodelling in giant cell arteritis. Rheumatology (Oxford). 2020. PMID: 32594153. doi:10.1093/rheumatology/keaa204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。